BioCryst Pharmaceuticals, Inc.BCRXNASDAQ
Loading
Total Costs & Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+8.4%
5Y CAGR+22.6%
Year-over-Year Change
Total of all costs and expenses
3Y CAGR
+8.4%/yr
vs +38.2%/yr prior
5Y CAGR
+22.6%/yr
Recent deceleration
Acceleration
-29.8pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.8x
Strong expansion
Streak
9 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $533.85M | +17.8% |
| 2024 | $453.25M | +4.2% |
| 2023 | $435.12M | +3.8% |
| 2022 | $419.26M | +25.2% |
| 2021 | $334.89M | +73.9% |
| 2020 | $192.57M | +29.9% |
| 2019 | $148.29M | +29.1% |
| 2018 | $114.87M | +39.1% |
| 2017 | $82.60M | +10.2% |
| 2016 | $74.96M | - |